European Respiratory Society
banner
europeanrespsoc.bsky.social
European Respiratory Society
@europeanrespsoc.bsky.social
A non-profit organisation dedicated to sharing scientific knowledge, fighting lung disease and promoting lung health. ERS has more than 35,000 members worldwide. ersnet.org
AI-based analytics of bronchiectasis research highlights evolving trends and emerging priorities, and reveals an expanding research landscape that is shifting from disease to patient centricity, which is in early development compared to asthma and COPD https://bit.ly/3J82wUc
December 6, 2025 at 4:13 PM
European Respiratory Journal: The CFTR triple modulator elexacaftor/tezacaftor/ivacaftor exerts sustained effects on systemic inflammation and lung function in children, adolescents and adults with CF in a real-world, post-approval setting https://bit.ly/45hTdK9
December 6, 2025 at 2:58 PM
Support the @europeanlung.bsky.social’s festive stars campaign to make a difference for respiratory patients ⭐

All donations will support the charity’s patient-led activities, information and resources for the year ahead. Learn more and donate: https://bit.ly/4pyMAu1
December 6, 2025 at 1:23 PM
ERJ: Short telomere length (<10th percentile) in patients with RA-ILD is associated with more severe baseline respiratory impairment and faster decline in lung function. Telomere length measurement may improve risk stratification in these patients. https://bit.ly/41gwqMd
December 5, 2025 at 5:52 PM
We need your input: survey on the environmental impact of digital technologies used in respiratory research!

The ERS CRC, CONNECT, is inviting ERS members to take part in a short survey aiming to support sustainable practices in digital research.

Complete the survey: https://bit.ly/4ryizME
December 5, 2025 at 3:54 PM
ERJ Open Research: Children and adolescents with PIBO exhibit reduced cardiorespiratory fitness due to ventilatory limitations. This impairment is associated with lung function, muscle strength, age, body mass index, quality of life and female sex. https://bit.ly/40dErkr
December 5, 2025 at 2:06 PM
Idiopathic pulmonary fibrosis-associated mortality rates have increased globally, particularly in males. There are significant geographical, age and sex disparities, emphasising the need for targeted public health measures and improved disease management. https://bit.ly/3Z5iRy3
December 4, 2025 at 5:54 PM
ERJOR: This randomised controlled trial showed that respiratory muscle training through shankh blowing reduced daytime sleepiness, improved subjective sleep quality and significantly decreased the apnoea–hypopnoea index in individuals with moderate OSA https://bit.ly/4mOyGU1
December 4, 2025 at 5:10 PM
ERJ Open Research: Remote sputum collection is feasible and favourable in people with cystic fibrosis in the era of CFTR modulators. Yet, validation of home sputum collection and delayed processing is necessary. https://bit.ly/43Xr0X7
December 4, 2025 at 4:14 PM
🚭 #COP11 decisions align with three key ERS priorities 🚭


Learn more about our efforts in Geneva, Switzerland, to advance global tobacco control policies: https://bit.ly/4iz1A94

📽️ Here’s Dr Filippos Filippidis on his COP11 experience . . .



December 3, 2025 at 7:24 PM
ERJ Open Research: Pectoral muscle area derived from a chest computed tomography performed as part of routine care is reliable for identifying quadriceps weakness in COPD patients https://bit.ly/3SrBska
December 3, 2025 at 5:57 PM
ERJ: Interstitial lung abnormalities (ILA) and coronary heart disease (CHD) share common risk factors. ILA commonly co-occur with CHD and are associated with worse survival, suggesting that ILA are a clinically important comorbidity in patients with CHD. https://bit.ly/3ZNf4po
December 3, 2025 at 3:46 PM
Eur Respir J: Obstructive sleep apnoea increases cardiovascular and mortality risks. This study of 5358 patients followed over 14 years shows PAP therapy reduces long-term MACE and death risks by 16%. A calculator to estimate patient risk was created. https://bit.ly/40ZpMde
December 3, 2025 at 1:13 PM
ERR: Air pollution, especially from PM2.5 and NO2, is linked to higher risk of acute lower respiratory infections mortality and incidence. Rigorous systematic reviews are needed to better assess short-term effects and support public health policies. https://bit.ly/46URsls
December 2, 2025 at 6:12 PM
ERJ: This study examined physiological markers linking OSA to cognitive impairment and found that blunted EEG and heart rate responses to respiratory events were associated with poorer cognitive performance, offering insight into underlying mechanisms https://bit.ly/4mxuveo
December 2, 2025 at 4:08 PM
European Respiratory Review: A review focusing on hyperconcentrated mucus and the small airways in paediatric bronchiectasis https://bit.ly/4nsPWOe
December 2, 2025 at 3:10 PM
ERR: Electronic cigarettes pose respiratory risks, including inflammation and airway damage. This review summarises cell, animal and human studies, emphasising the need for standardised research to clarify their long-term impact on respiratory health. https://bit.ly/47EYk8E
December 1, 2025 at 5:52 PM
Most deaths in HIV patients are caused by TB.

On #WorldAIDSDay 2025, the Forum of International Respiratory Societies (FIRS) and @atscommunity.bsky.social are highlighting the impact of funding cuts on advances in TB diagnosis and treatment.

Read more: https://bit.ly/4afkJKW
December 1, 2025 at 4:13 PM
ERR: This systematic review shows most ILD clinical guidance documents focus on diagnosis and pharmacotherapies, with limited coverage of other aspects of patient care. Future guidance documents need to address the gaps for comprehensive ILD care. https://bit.ly/44B60XJ
December 1, 2025 at 2:52 PM
The #Respiratory Failure and Mechanical Ventilation Conference 2026 offers cutting-edge scientific sessions and interactive educational content.

📆 12–14 February, 2026
🌍 Rotterdam, Netherlands
💻 In-person and online

Register your place: bit.ly/4iAt5xa
December 1, 2025 at 9:00 AM
ERJ Open Research: Drugs and toxins may induce pulmonary arterial hypertension, with a frequently updated list https://bit.ly/43gmAtI
November 28, 2025 at 1:54 PM
Biallelic SERPINA1 Q0 variants lead to early-onset emphysema even in nonsmokers, mandating early-life preventive and therapeutic measures. ZZ patients' lungs on shut-off transcription strategies equating them to “null” variants should also be protected. https://bit.ly/4mIlRL9
November 27, 2025 at 4:05 PM
ERJ Open Research: Climate change and global warming may increase NTM infection incidence. In Italy, subjects who live in hotter, less ventilated climates with reduced precipitation and higher degree of urbanisation are at higher risk of NTM infection. https://bit.ly/3YBufS3
November 26, 2025 at 4:12 PM
ERJ Open Research: Airway abnormalities and treatable traits https://bit.ly/4ox58L4
November 25, 2025 at 6:13 PM
This study revealed 39% prevalence of low adherence (LA) to diuretics over 12 months. It suggests that LA to diuretics was associated with worse outcomes. Potential risk factors for LA include younger age, active employment and high perceived PH knowledge. https://bit.ly/4li8IYe
November 25, 2025 at 3:49 PM